Antimicrobial Resistance and Mortality in Carbapenem-Resistant Pseudomonas aeruginosa Infections in Southern Thailand
Antibiotics · 19.03.2025 · 14 (3) · 322
DOI: 10.3390/antibiotics14030322 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibiotics, online erschienen am 19.03.2025. Verfasst von Parichart Chotimakorn und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacotherapy Thailand, Nonthaburi 11000, Thailand. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Doctor Kasem Pangsrivongse Foundation, Thailand, Faculty of Medicine, Faculty of Pharmacy, and Faculty of Science, Prince of Songkla University., Doctor Kasem Pangsrivongse Foundation.
Abstract (Originalsprache)
Background/Objectives: Carbapenem-resistant Pseudomonas aeruginosa (CRPA) is an important pathogen associated with high mortality and treatment failure rates. We aimed to assess the susceptibility of CRPA to antipseudomonal agents, identify its resistance mechanisms, and evaluate clinical outcomes in a sample of CRPA isolates.
Methods
This was an in vitro study of a clinical isolate of CRPA from hospitalized patients with CRPA infection and a retrospective observational study of these patients, who were diagnosed between 14 February 2021 and 10 August 2023 at Songklanagarind Hospital in Songkhla, Thailand. In vitro experiments were conducted to determine the minimum inhibitory concentrations (MICs) of the antipseudomonal agents using the broth microdilution method. Resistance mechanisms were assessed using the modified carbapenem inactivation method, combined disk tests, and quantitative real-time reverse transcription polymerase chain reaction.
Results
A total of 140 CRPA isolates were analyzed. Both traditional and novel β-lactams had high MICs. The most common resistance mechanism was the upregulation of the MexAB-OprM efflux pump (81.3%), followed by the downregulation of the OprD porin (48.9%) and metallo-β-lactamase (MBL) production (45.0%), and the overexpression of blaAmpC (41.0%). The 30-day all-cause mortality rate was 30.5%. The risk factors associated with 30-day mortality included a Charlson Comorbidity Index of ≥5 (OR: 3.43; 95% CI: 1.07–10.99; p = 0.03), sepsis (OR: 10.62; 95% CI: 1.26–89.44; p = 0.03), and septic shock (OR: 4.39; 95% CI: 1.67–11.55; p < 0.01). In contrast, receiving active documented therapy was significantly associated with reduced mortality (OR: 0.17; 95% CI: 0.04–0.74; p = 0.01).
Conclusions
This study revealed higher MIC values of all β-lactams for CRPA, while colistin and amikacin remained effective. The resistance mechanisms included MexAB-OprM overexpression, OprD downregulation, MBL production, and blaAmpC overexpression, with a higher prevalence of MBL than in other regions of Thailand. High 30-day mortality was associated with comorbidities, sepsis, and septic shock, but active therapy reduced mortality.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Pharmacotherapy Thailand, Nonthaburi 11000, Thailand.
- Department of Pharmacy, Bhumibol Adulyadej Hospital, Bangkok 10220, Thailand.
- Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Songkhla 90110, Thailand.
- Department of Pharmacy, Faculty of Pharmacy, Silpakorn University, Nakorn Pathom 73000, Thailand.
- Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Songkhla 90110, Thailand.
- Department of Pathology, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.
ORCID-Profile: Parichart Chotimakorn, Wichai Santimaleeworagun, Pimpimon Tansakul, Mingkwan Yingkajorn, Rattanaruji Pomwised, Arnon Chukamnerd, Sarunyou Chusri
Förderung
- Doctor Kasem Pangsrivongse Foundation, Thailand
- Faculty of Medicine, Faculty of Pharmacy, and Faculty of Science, Prince of Songkla University.
- Doctor Kasem Pangsrivongse Foundation
- Faculty of Medicine, Faculty of Pharmacy, and Faculty of Science at the Prince of Songkla University
Zitieren
APA
Chotimakorn, P., Pattharachayakul, S., Lertsrisatit, Y., Santimaleeworagun, W., Tansakul, P., Yingkajorn, M., Chelae, S., Pomwised, R., Chukamnerd, A., Soontarach, R., & Chusri, S. (2025). Antimicrobial Resistance and Mortality in Carbapenem-Resistant Pseudomonas aeruginosa Infections in Southern Thailand. Antibiotics, 14(3), 322. https://doi.org/10.3390/antibiotics14030322
Vancouver
Chotimakorn P, Pattharachayakul S, Lertsrisatit Y, Santimaleeworagun W, Tansakul P, Yingkajorn M, et al. Antimicrobial Resistance and Mortality in Carbapenem-Resistant Pseudomonas aeruginosa Infections in Southern Thailand. Antibiotics. 2025;14(3):322. doi:10.3390/antibiotics14030322
BibTeX
@article{Chotimakorn2025,
author = {Chotimakorn, Parichart and Pattharachayakul, Sutthiporn and Lertsrisatit, Yongyut and Santimaleeworagun, Wichai and Tansakul, Pimpimon and Yingkajorn, Mingkwan and Chelae, Sureerat and Pomwised, Rattanaruji and Chukamnerd, Arnon and Soontarach, Rosesathorn and Chusri, Sarunyou},
title = {Antimicrobial Resistance and Mortality in Carbapenem-Resistant Pseudomonas aeruginosa Infections in Southern Thailand},
journal = {Antibiotics},
year = {2025},
volume = {14},
number = {3},
pages = {322},
doi = {10.3390/antibiotics14030322}
}
EUVIMED